Specialty chemicals group DSM on Tuesday announced an increase in turnover of 9% in the second quarter, and operating profit of €345m compared with €290m in the year-earlier period and €311m in the first quarter.

‘We are pleased the momentum in our Nutrition business continued into Q2,’ CEO Feike Sijbesma said in a statement.

‘For the rest of this year, we will continue fully focus on operational performance and on the integration of our acquisitions. We expect strong growth in 2013, moving towards €1.4bn,’ Sijbesma said.